Skip to main content
. 2022 Sep 13;10(5):e00547-22. doi: 10.1128/spectrum.00547-22

FIG 2.

FIG 2

Antibacterial effects of WYBQ-4 on clinically isolated S. aureus strains. (A to D) The antimicrobial effect of (A) WYBQ-4, (B) moxalactam, or (C) cefepime on clinically isolated MRSA was determined by measuring the MIC and (D) the coefficient of variance of clinically isolated MRSA. (E to H) The antimicrobial effect of (E) WYBQ-4, (F) moxalactam, or (G) cefepime on clinically isolated MSSA was determined by measuring the MIC and (H) the coefficient of variance of clinically isolated MSSA.